Figure 2.
EVs from stored murine platelets elicit endothelial barrier dysfunction. (A) Group data show TEER (measured in ohms) as ratio relative to initial monolayer resistance of primary HPMECs cultured for 4 hours with PBS, EVs from platelets stored for 1 (D1-EVs) or 5 (D5-EVs) days. EVs were dosed volumetrically (diamonds) using a similar strategy as in the in vivo experiments. (B) For each individual TEER measurement, the area under the curve (AUC) relative to the baseline y = 1.0 was calculated and is given as group data for endothelial permeability, with increased AUC indicating loss of resistance (increased permeability), whereas 0 or negative values indicate maintenance of or increased endothelial barrier function. (C) Group data show TEER in HPMEC monolayers cultured with PBS, or equal numbers (circles; 5 × 105 EVs each instead of volumetric dosing as seen in panels A-B) of D1-EVs, D3-EVs, or D5-EVs. Day 5 platelet- and EV-depleted platelet pools (D5 non-EV) were administered in identical volumes (5 µL) as D5-EVs Corresponding calculated AUCs are given in panel D. Group data are depicted as mean ± SD; n = 5-8 each. *P < .05 vs PBS only, #P < .05 vs D1-EVs and †P < .05 vs D5 non-EV (1-way analysis of variance and post hoc all pairwise Tukey test).

EVs from stored murine platelets elicit endothelial barrier dysfunction. (A) Group data show TEER (measured in ohms) as ratio relative to initial monolayer resistance of primary HPMECs cultured for 4 hours with PBS, EVs from platelets stored for 1 (D1-EVs) or 5 (D5-EVs) days. EVs were dosed volumetrically (diamonds) using a similar strategy as in the in vivo experiments. (B) For each individual TEER measurement, the area under the curve (AUC) relative to the baseline y = 1.0 was calculated and is given as group data for endothelial permeability, with increased AUC indicating loss of resistance (increased permeability), whereas 0 or negative values indicate maintenance of or increased endothelial barrier function. (C) Group data show TEER in HPMEC monolayers cultured with PBS, or equal numbers (circles; 5 × 105 EVs each instead of volumetric dosing as seen in panels A-B) of D1-EVs, D3-EVs, or D5-EVs. Day 5 platelet- and EV-depleted platelet pools (D5 non-EV) were administered in identical volumes (5 µL) as D5-EVs Corresponding calculated AUCs are given in panel D. Group data are depicted as mean ± SD; n = 5-8 each. *P < .05 vs PBS only, #P < .05 vs D1-EVs and †P < .05 vs D5 non-EV (1-way analysis of variance and post hoc all pairwise Tukey test).

Close Modal

or Create an Account

Close Modal
Close Modal